Answered

Get the most out of your questions with IDNLearn.com's extensive resources. Get the information you need from our community of experts who provide accurate and thorough answers to all your questions.

Which of the following are arguments against direct-to-consumer pharmaceutical advertising (DTCPA)? Select all that apply.

A. Encourages overutilization of drugs
B. Strains the patient-provider relationship
C. Educates, empowers, and informs the public
D. Encourages patient compliance
E. Reduces underdiagnosis and undertreatment of some diseases

Sagot :

GinnyAnsweridn

Final answer:

DTCPA has drawbacks such as promoting overutilization of drugs, straining the patient-provider relationship, and potentially reducing underdiagnosis and undertreatment of diseases.


Explanation:

Arguments against direct-to-consumer pharmaceutical advertising (DTCPA) include:

  • Encourages overutilization of drugs: DTCPA can lead to patients requesting unnecessary medications.
  • Strains the patient-provider relationship: By influencing patients' demands, DTCPA can disrupt the trust and communication between patients and healthcare providers.
  • Reduces underdiagnosis and undertreatment of some diseases: DTCPA may prioritize expensive treatments over necessary preventive care or non-pharmacological interventions.

Learn more about Arguments against direct-to-consumer pharmaceutical advertising (DTCPA) here:

https://brainly.com/question/29530544


Thank you for contributing to our discussion. Don't forget to check back for new answers. Keep asking, answering, and sharing useful information. IDNLearn.com is committed to your satisfaction. Thank you for visiting, and see you next time for more helpful answers.